Resources
Ten Mistakes to Avoid when Searching Gene Sequences
Avoid the costly pitfalls of inaccurate, irrelevant, and untimely search results - what you need to consider before your next search.
Learn More»
The value of a cost-effective informatics platform that enables rapid and relevant search of the vast universe of sequences and their patents with regard to commercialization of new drugs cannot be understated. This is particularly true in the fast-paced R&D area of infectious disease research. We selected GenomeQuest™ for its ability to instantly locate sequence data and display it in an intuitive and easily manipulated format.
Director of Research (Anti-Infectives) and Manager, Intellectual Property
GenomeQuest has over 120 customers worldwide, and is relied on by 6 of the top 10 biotech firms, 7 of the top 10 pharma, and 10 leading biotechnology law practices.
Our customers (partial list)
Amgen
Applied Biosystems
ARYx Therapeutics
Axxam
Biogen Idec
BioMerieux
Biogemma
Celera
Cell Signaling Technology
Chiron
Choate Hall & Stewart
CIPO
Dyax
European Patent Office (EPO)
Euroscreen
Falco Archer
Foley Hoag
Gen-Probe
Hybrigenics
Idexx Laboratories
ImClone Systems
Migenix
Millennium Pharmaceuticals
MerckSerono
Monsanto
Organon
Pfizer-Groton
Pioneer Hi-Bred (a DuPont Company)
Procter & Gamble
Regeneron Pharmaceuticals
Ribovax
Sanofi-Aventis
Servier Labs
Sterne, Kessler, Goldstein, Fox
Syngenta Biotechnology
Third Wave Technologies
Customer Stories
Read about how GenomeQuest's customers are engaging in collaborative efforts, and using the GenomeQuest product to improve productivity, simplify search processes, manage results, and more.
Chiron
CIPO (Canadian Intellectual Property Office)
Falco Archer
Pfizer
Servier Labs
Sterne, Kessler, Goldstein & Fox
Why Our Customers Use GenomeQuest
GenomeQuest has gained rapid market share against established services and databases in only two years. Why? By demonstrating rapid Return On Investment (ROI). According to our customers, GenomeQuest:
- produces patent landscape reports faster (in just 1-2 hours)
- is easy to use, so more people in the organization can do searches themselves, saving time and human labor
- finds more relevant records in its database, increasing confidence
- has a flexible and affordable license policy, so small and large organizations can deploy it widely
- is updated with new records continuously, avoiding missed competitor activities
- provides a total solution (search/analytics/reports, biology+patent content, continuous updates), lowering administration costs
In short, GenomeQuest allows better research decision-making earlier in the research process to optimize the research portfolio thru "fail early, fail often."